Objective: Government-imposed physical distancing restrictions during the COVID-19 pandemic disrupted biobehavioral HIV prevention practices and access to healthcare services. This study aimed to use a mathematical model to evaluate the impact of COVID-19 on the HIV epidemic among MSM in Australia, using empirical data. Design: A retrospective modeling study. Methods: We developed a mathematical model to estimate monthly HIV incidence between January 2020 and August 2022. We obtained aggregated monthly data for sexual partners, condom use, HIV testing, preexposure prophylaxis (PrEP) use, and migration. Three scenarios were simulated: a COVID-19 scenario; a no COVID-19 scenario where input parameters remained at pre-COVID-19 values; and a no COVID-19 scenario with continued PrEP scale-up. Results: In the absence of the COVID-19 pandemic, 1263 (95% percentile interval: 880–1706) infections would have occurred between January 2020 and August 2022 compared to 915 (95% percentile interval: 638–1282) for the COVID-19 scenario (a 27.6% reduction). Reduced sexual partners was the leading factor contributing to the change in HIV infections and diagnoses (-24.9 and -10.6%, respectively). MSM aged at least 50 years had a larger reduction (31.0%) in new HIV infections than their younger counterparts (19.9%). Conclusion: A substantial reduction in new HIV infections and diagnoses in Australia occurred during the COVID-19 pandemic, largely due to decreased numbers of sexual partners. This reduction underscores the need for sustained public health strategies leveraging reduced transmission rates to continue progress toward eliminating HIV in Australia.
Genital Chlamydia trachomatis (CT) is one of the most common sexually transmitted infections (STI) worldwide. We explored the factors associated with willingness to participate in partner notification (PN) among women attending reproductive health and STI clinics in Shenzhen, China. An anonymous questionnaire was used to collect the sociodemographic characteristics, STI histories, and willingness to participate in routine CT screening and partner notification. In total, 87.31% (n = 10,780) of participants were willing to notify their sex partner(s) if they were diagnosed with a CT infection. Willingness to complete PN was significantly associated with: being married, residing in Shenzhen ≥1 year, having completed junior college or higher, not currently reporting STI-related symptoms, willing to have routine CT screening, and having a correct understanding of the health sequelae of CT infection. Nearly all women surveyed at reproductive health and STI clinics in Shenzhen reported willingness to complete PN. Promoting PN in these settings could help detect a large number of additional CT cases. Our findings provide evidence and implications for public health interventions on PN and suggest that targeted interventions are urgently needed for particular subpopulations including those not currently married, with shorter residency, lower education, and less awareness about the dangers of CT infection.
Introduction The initial phase of the coronavirus disease 2019 (COVID-19) pandemic caused significant interruptions to human immunodeficiency virus (HIV) prevention and healthcare services. In Australia, these interruptions coincided with a large reduction in HIV diagnoses but it is unknown if this reflects a reduction in incidence or barriers to testing. We aimed to understand the changes in HIV transmission among men who have sex with men in Australia and the impact of disruptions to HIV prevention, testing and treatment services due to the COVID-19 pandemic and the public health response by incorporating time-sensitive factors in real-world situations. Methods We developed a mathematical model to estimate monthly HIV incidence between January 2020 and August 2022. We obtained aggregated monthly data for sexual partners, condom use, HIV testing, pre-exposure prophylaxis (PrEP) use, and migration. Three scenarios were simulated: 1) a COVID scenario with all changes in place; 2) a no COVID-19 scenario where input parameters remained at pre-COVID-19 values, and 3) a no COVID-19 scenario with continued PrEP scale-up. Results In the absence of the COVID-19 pandemic, the estimated number of cumulative infections from January 2020 to August 2022 would have been 1,266 [95% Percentile Interval (PI): 1,100–1,466] compared to 915 [95% PI: 729–1,181] for the COVID-19 scenario (a 27.7% reduction). The largest reduction in infections (44.3%) occurred in 2020 with 273 (95% PI: 221– 344) infections versus 490 (95% PI: 435–552) in the no-COVID scenario. There was a rebound with 387 infections (95% PI: 307–502) in 2021, followed by a reduction to a stable level by August 2022. Our model identified reductions in sexual partners as the leading factor contributing to the change in HIV infections and diagnoses (−24.8% and −10.5%, respectively). Conclusions A substantial reduction in new HIV infections and diagnoses in Australia occurred during the early stages of the COVID-19 pandemic, which was largely due to reduced HIV transmission. A rebound in infections as sexual partnerships increased between 2021-2022, highlights the imperative to maintain vigorous response efforts and take advantage of the gains made to virtually eliminate HIV transmission in Australia.